Chennai: Pharma major Dr Reddy’s has reported a consolidated net profit of Rs 992 crore for the September quarter, up 30 per cent from Rs 762 crore in the same quarter of last year.
The company also reported an 18 per cent on-year rise in consolidated revenues to Rs 5,763 crore for the reported quarter.
The growth of the company was led by its global generics and proprietary drugs business during the quarter. The proprietary products business saw its sales rise 195 per cent YoY to Rs 182.9 crore during the quarter.